In the last week, the United States market has remained flat, although it has experienced a 16% increase over the past year with earnings projected to grow by 15% annually in the coming years. In this context of steady growth and positive earnings outlook, identifying stocks that are potentially trading below their estimated value can offer investors an opportunity to capitalize on undervalued assets.

Top 10 Undervalued Stocks Based On Cash Flows In The United States

Name	Current Price	Fair Value (Est)	Discount (Est)
WesBanco (WSBC)	$30.51	$58.39	47.8%
Valley National Bancorp (VLY)	$9.39	$18.32	48.7%
RXO (RXO)	$15.44	$30.14	48.8%
Peoples Financial Services (PFIS)	$48.45	$93.66	48.3%
Pennant Group (PNTG)	$22.57	$44.18	48.9%
Gogo (GOGO)	$16.43	$32.45	49.4%
Definitive Healthcare (DH)	$4.00	$7.86	49.1%
Camden National (CAC)	$37.11	$72.87	49.1%
BioLife Solutions (BLFS)	$21.82	$42.15	48.2%
AGNC Investment (AGNC)	$9.60	$18.61	48.4%

Let's uncover some gems from our specialized screener.

Intuit (INTU)

Overview: Intuit Inc. offers financial management, compliance, and marketing products and services in the United States with a market cap of $224.93 billion.

Operations: Intuit's revenue is primarily driven by its Global Business Solutions segment at $10.62 billion, followed by the Consumer segment at $4.85 billion and Credit Karma at $2.10 billion, with Pro-Tax contributing $618 million.

Estimated Discount To Fair Value: 10.6%

Intuit's stock appears undervalued based on discounted cash flow analysis, trading at US$807.39 against a fair value estimate of US$903.34. Despite significant insider selling recently, Intuit's revenue and earnings are projected to grow faster than the broader market, driven by strategic alliances like the one with iBusiness Funding and product enhancements such as AI-driven QuickBooks features that optimize cash flows for businesses. These factors support its potential for long-term value creation.

GeneDx Holdings (WGS)

Overview: GeneDx Holdings Corp. is a genomics company that offers genetic testing services and has a market cap of approximately $2.64 billion.

Operations: GeneDx Holdings Corp. generates revenue primarily through its genetic testing services.

Estimated Discount To Fair Value: 44.5%

GeneDx Holdings is trading well below its estimated fair value of US$186.56, with a current price of US$103.51, highlighting potential undervaluation based on cash flows. The company has turned profitable this year and revised its 2025 revenue guidance upwards to between US$400 million and US$415 million. Despite recent index exclusions, GeneDx's earnings are forecasted to grow significantly at 44.75% annually, driven by advancements in genomic testing technologies and expanded insurance coverage for these services.

e.l.f. Beauty (ELF)

Overview: e.l.f. Beauty, Inc. is a global beauty company offering cosmetics and skin care products, with a market cap of approximately $6.80 billion.

Operations: The company generates revenue of $1.31 billion from its Personal Products segment, which includes cosmetics and skin care products sold globally.

Estimated Discount To Fair Value: 36.1%

e.l.f. Beauty is trading at US$123.28, significantly below its estimated fair value of US$193, suggesting undervaluation based on cash flows. Despite a dip in profit margins and significant insider selling recently, earnings are forecast to grow 20.5% annually, outpacing the broader US market's growth rate. The company's strategic shift from Russell Growth to Value indices may reflect its evolving financial profile amidst robust revenue expansion in international markets and partnerships like Hello Sunshine's Sunnie initiative.

Next Steps

• Click here to access our complete index of 170 Undervalued US Stocks Based On Cash Flows.
• Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.
• Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world.

Interested In Other Possibilities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.